Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
BI

Bryan Irving — 15 Patents

Genentech: 8 patents #386 of 2,392Top 20%
CTCytomx Therapeutics: 5 patents #21 of 70Top 30%
APAmunix Pharmaceuticals: 1 patents #15 of 28Top 55%
Woodside, CA: #98 of 553 inventorsTop 20%
California: #40,789 of 386,348 inventorsTop 15%
Overall (All Time): #307,048 of 4,157,543Top 8%
15 Patents All Time
Bryan Irving has been granted 15 US patents while listed as an inventor at Genentech. The first was granted in 2012 and the most recent in November 2025. Bryan Irving ranks #307,048 of 4,157,543 US inventors in our database (top 7.4%). Patent records list Bryan Irving in Woodside, CA, US.

Patents per Year

Patents granted per year, 2012 to 2025Bar chart with a peak of 4 patents in 2020.peak 42012: 1 patents20122017: 1 patents20172018: 3 patents20182020: 4 patents20202021: 1 patents20212022: 1 patents20222023: 1 patents20232024: 1 patents20242025: 2 patents2025

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12460017 Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof Leila Marie Boustany, Sherry Lynn La Porte, Jeanne Grace Flandez 2025-11-04
12215156 HER-2 targeted bispecific compositions and methods for making and using the same Volker Schellenberger, Eric Johansen, Angela HENKENSIEFKEN, Darragh MacCann, James McClory +3 more 2025-02-04
11859010 Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof Leila Marie Boustany, Sherry Lynn La Porte, Jeanne Grace Flandez 2024-01-02 $1,734,000
11802158 Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same Sherry Lynn La Porte, Jason Gary Sagert, Daniel Robert Hostetter, Olivia Jennifer RAZO, Clayton William White +1 more 2023-10-31 $1,377,000
11472889 Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof Leila Marie Boustany, Sherry Lynn La Porte, Jeanne Grace Flandez 2022-10-18 $926,000
11161906 Multispecific antibodies, multispecific activatable antibodies and methods of using the same Henry B. Lowman, James William West, Sherry Lynn La Porte, Daniel Robert Hostetter, Chihunt Wong 2021-11-02 $5,178,000
10669337 Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same Sherry Lynn La Porte, Jason Gary Sagert, Daniel Robert Hostetter, Olivia Jennifer RAZO, Clayton William White +1 more 2020-06-02 $3,753,000
10646567 Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors Heather Maecker 2020-05-12
10626174 Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors Jane L. GROGAN, Robert J. Johnston, Jason A. Hackney, Xin Yu, Dan Eaton +2 more 2020-04-21
10611836 Methods of treating cancer using PD-1 axis binding antagonists and tigit inhibitors Jane L. GROGAN, Robert J. Johnston, Jason A. Hackney, Xin Yu, Dan Eaton +2 more 2020-04-07
9920123 Anti-PD-L1 antibodies, compositions and articles of manufacture Henry Chiu, Heather Maecker, Sanjeev Mariathasan, Sophie M. Lehar, Yan Wu +1 more 2018-03-20
9895441 Methods of treating cancer using PD-L1 axis binding antagonists and VEGF antagonists Heather Maecker 2018-02-20
9873740 Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors Jane L. GROGAN, Robert J. Johnston, Jason A. Hackney, Xin Yu, Dan Eaton +2 more 2018-01-23
9724413 Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors Heather Maecker 2017-08-08
8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture Henry Chiu, Heather Maecker, Sanjeev Mariathasan, Sophie M. Lehar, Yan Wu +1 more 2012-07-10